SCHEMBL2345155

SCHEMBL2345155

Fc1cccc(-n2c(N3CCNCC3)cc3ccccc32)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 8/20 0.44
▸ HTR7 P34969 6/20 0.44
▸ SLC6A4 P31645 3/20 0.42
▸ SLC6A2 P23975 2/20 0.42
▸ HTR3E A5X5Y0 5/20 0.42
▸ HTR3B O95264 5/20 0.42
▸ HTR3A P46098 5/20 0.42
▸ HTR3D Q70Z44 5/20 0.42
▸ HTR3C Q8WXA8 5/20 0.42
▸ SIGMAR1 Q99720 5/20 0.42
▸ HTR5A P47898 2/20 0.42
▸ HTR6 P50406 6/20 0.41
▸ HTR2A P28223 5/20 0.41
▸ HTR2C P28335 5/20 0.41
▸ HTR1D P28221 3/20 0.41
▸ ADRB1 P08588 3/20 0.41
▸ HTR1B P28222 2/20 0.41
▸ HTR2B P41595 2/20 0.41
▸ DRD2 P14416 1/20 0.41
▸ KDR P35968 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11555106 0.86 HTR3E (0.53) HTR1AHTR7SLC6A4HTR3EHTR3B
SCHEMBL2346242 0.84 ADRB1 (0.60) HTR1AHTR7SLC6A4HTR3EHTR3B
SCHEMBL2348220 0.82 ADRB1 (0.62) HTR1AHTR7HTR3EHTR3BHTR3A
SCHEMBL2343308 0.81 SOS1 (0.47) HTR1AHTR7SLC6A4HTR3EHTR3B
SCHEMBL2343964 0.79 HTR7 (0.49) HTR1AHTR7SLC6A4HTR3EHTR3B
SCHEMBL2345082 0.78 HTR3E (0.48) HTR1AHTR7HTR3EHTR3BHTR3A
SCHEMBL2346369 0.78 ADRB1 (0.53) HTR1AHTR7SLC6A4HTR3EHTR3B
SCHEMBL315894 0.76 HTR7 (0.68) HTR1AHTR7SLC6A4HTR3EHTR3B
SCHEMBL2350412 0.76 HTR6 (0.63) HTR1AHTR7HTR3EHTR3BHTR3A
SCHEMBL2342043 0.75 HTR3A (0.56) HTR1AHTR7HTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008491-B2 poly(adenosine 5'-diphosphate ribose) polymerase inhibitors such as 1-phenyl-2-(piperazin-1-yl)-1,3-dihydropyrrolo[2,3-b]pyridine-3-carboxaldehyde, used in the treatment and/or prevention central nervous system and cardiovascular disorders AVENTIS PHARMACEUTICALS, INC. (US) 2011-08-30 — — US disclosed
Send feedback